WellTheory Raises $14M Series A Led by General Catalyst to Fuel Growth and AI Development

Deal Summary

WellTheory, a virtual whole-person care platform for autoimmune disease, raised $14 million in a Series A round led by General Catalyst with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer, and Up2 Opportunity Fund. The funding will support commercial expansion, accelerate AI development, and expand employer and payor programs.